0.3(top 100%)
impact factor
161(top 50%)
papers
1.6K(top 50%)
citations
20(top 50%)
h-index
0.3(top 100%)
impact factor
170
all documents
1.6K
doc citations
34(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1The Severe Chronic Neutropenia International Registry: 10-Year Follow-up ReportSupportive Cancer Therapy2006135
2Epidemiology of Febrile NeutropeniaSupportive Cancer Therapy200392
3Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 AntagonistSupportive Cancer Therapy200491
4Oral Complications and Management Considerations in Patients Treated with High-Dose ChemotherapySupportive Cancer Therapy200455
5Symptom Clusters in Patients with Advanced-Stage Cancer Referred for Palliative Radiation Therapy in an Outpatient SettingSupportive Cancer Therapy200754
6Treatment of Bone Metastases and Bone Pain with BisphosphonatesSupportive Cancer Therapy200746
7Unique Aspects of Supportive Care Using Monoclonal Antibodies in Cancer TreatmentSupportive Cancer Therapy200338
8Preoperative Assessment of Cancer in Elderly Patients: A Pilot StudySupportive Cancer Therapy200337
9Chemotherapy-Induced Emesis: Quality of Life and Economic Impact in the Context of Current Practice in CanadaSupportive Cancer Therapy200537
10Final Results of a Placebo-Controlled Study of Filgrastim in Small-Cell Lung Cancer: Exploration of Risk Factors for Febrile NeutropeniaSupportive Cancer Therapy200536
11Tumor Lysis Syndrome in Solid TumorsSupportive Cancer Therapy200536
12A Phase II/III Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Ginger (Zingiber officinale) for Nausea Caused by Chemotherapy for Cancer: A Currently Accruing URCC CCOP Cancer Control StudySupportive Cancer Therapy200734
13The Correlation Among Patients and Health Care Professionals in Assessing Functional Status Using the Karnofsky and Eastern Cooperative Oncology Group Performance Status ScalesSupportive Cancer Therapy200431
14Chemotherapy-Induced Palmar-Plantar Erythrodysesthesia Syndrome: Etiology and Emerging TherapiesSupportive Cancer Therapy200428
15Decision-Making Role Preferences of Patients Receiving Adjuvant Cancer Treatment: A University of Rochester Cancer Center Community Clinical Oncology ProgramSupportive Cancer Therapy200428
16Group Medical Appointments: Organization and Implementation in the Bone Marrow Transplantation ClinicSupportive Cancer Therapy200627
17Survival-Adjusted Multiple-Event Analysis for the Evaluation of Treatment Effects of Zoledronic Acid in Patients with Bone Metastases from Solid TumorsSupportive Cancer Therapy200526
18A Comparison of Radiation Therapy Outcomes of Bone Metastases Employing International Consensus Endpoints and Traditional EndpointsSupportive Cancer Therapy200425
19Role of Bisphosphonates for the Management of Skeletal Complications and Bone Pain from Skeletal MetastasesSupportive Cancer Therapy200625
20The Effect of Palifermin on Chemotherapyand Radiation Therapy–Induced Mucositis: A Review of the Current LiteratureSupportive Cancer Therapy200724
21Strategies for Pain Management: Cleveland Clinic Foundation Guidelines for Opioid Dosing for Cancer PainSupportive Cancer Therapy200421
22Novel Neurokinin-1 Antagonists as Antiemetics for the Treatment of Chemotherapy-Induced EmesisSupportive Cancer Therapy200620
23Weekly Administration of Epoetin Alfa Improves Cognition and Quality of Life in Patients with Breast Cancer Receiving ChemotherapySupportive Cancer Therapy200419
24The Role of Methadone in the Treatment of Moderate to Severe Cancer PainSupportive Cancer Therapy200518
25Dehydroepiandrosterone for the Treatment of Hot Flashes: A Pilot StudySupportive Cancer Therapy200618
26Mucositis Management in Patients with CancerSupportive Cancer Therapy200618
27Rapid and Sustained Influence of Intravenous Zoledronic Acid on Course of Pain and Analgesics Consumption in Patients with Cancer with Bone Metastases: A Multicenter Open-Label Study Over 1 YearSupportive Cancer Therapy200718
28Prevention and Treatment of Salivary Gland Hypofunction Related to Head and Neck Radiation Therapy and ChemotherapySupportive Cancer Therapy200417
29Adverse Effects of Bevacizumab and Their Management in Solid TumorsSupportive Cancer Therapy200617
30Catheter-Related Thrombosis: A Critical ReviewSupportive Cancer Therapy200717
31Benefits of GM-CSF Versus Placebo or G-CSF in Reducing Chemotherapy-Induced Complications: A Systematic Review of the LiteratureSupportive Cancer Therapy200416
32An Overview of the Management of Infection and Febrile Neutropenia in Patients with CancerSupportive Cancer Therapy200516
33Optimizing Management of Tumor Lysis Syndrome in Adults with Hematologic MalignanciesSupportive Cancer Therapy200516
34The Risk of Cumulative Renal Effects of Intravenous BisphosphonatesSupportive Cancer Therapy200616
35Topiramate in the Treatment of Neuropathic Pain in Patients with CancerSupportive Cancer Therapy200716
36Inhibiting Substance P Pathway for Prevention of Chemotherapy-Induced Emesis: Preclinical Data, Clinical Trials of Neurokinin-1 Receptor AntagonistsSupportive Cancer Therapy200415
37Venous Thromboembolism in Patients with Cancer and Its Relationship to the Coagulation Cascade and Vascular Endothelial Growth FactorSupportive Cancer Therapy200515
38Factor V Leiden Mutation in Patients with Breast Cancer with a Central Venous Catheter: Risk of Deep Vein ThrombosisSupportive Cancer Therapy200615
39Chocolate as a Cough Suppressant: Rationale and Justification for an Upcoming Clinical TrialSupportive Cancer Therapy200713
40Quality of Life after Local External Beam Radiation Therapy for Symptomatic Bone Metastases: A Prospective EvaluationSupportive Cancer Therapy200412
41Reasons for Poor Accrual in Palliative Radiation Therapy Research StudiesSupportive Cancer Therapy200612
42Abbreviated Rasburicase Dosing for the Prevention and Treatment of Hyperuricemia in Adults at Risk for Tumor Lysis SyndromeSupportive Cancer Therapy200611
43The Volume/Outcome Relationship in Urologic Cancer SurgerySupportive Cancer Therapy200410
44What Is the Evidence for Implantable Drug Delivery Systems for Refractory Cancer Pain?Supportive Cancer Therapy200410
45Kyphoplasty and Vertebroplasty for the Treatment of Spinal MetastasesSupportive Cancer Therapy200510
46Effect of Treatment with Epoetin Beta on Thromboembolic Events in Anemic Patients with Cancer: A MetaanalysisSupportive Cancer Therapy200610
47Pilot Evaluation of Aprepitant for the Treatment of Hot FlashesSupportive Cancer Therapy200610
48Phase II Evaluation of Desipramine for the Treatment of Hot FlashesSupportive Cancer Therapy200710
49Palmar-Plantar Erythrodysesthesia in Patients Receiving Capecitabine and Intratumor Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase: Is There a Pharmacologic Explanation?Supportive Cancer Therapy200710
50Management of Constipation in Patients with CancerSupportive Cancer Therapy20049